Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124992) titled 'The Value of 4D-Flow Cardiovascular Magnetic Resonance (CMR) in Assessing Hemodynamic Alterations and Predicting Adverse Outcomes in Patients with Hypertrophic Cardiomyopathy' on May 20.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Shanghai Tenth People's Hospital
Condition:
Hypertrophic cardiomyopathy
Intervention:
HCM group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-06-01
Target Sample Size: HCM group:200;Control group:50;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=323286
...